Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein
- 1 March 2002
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 317 (1), 85-94
- https://doi.org/10.1006/jmbi.2002.5403
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold 1 1Edited by J. KahnJournal of Molecular Biology, 2001
- Intrabody construction and expression. II. A synthetic catalytic Fv fragmentJournal of Molecular Biology, 1999
- Intrabody construction and expression. I. The critical role of VL domain stabilityJournal of Molecular Biology, 1999
- Expression of an antibody fragment at high levels in the bacterial cytoplasmJournal of Molecular Biology, 1998
- An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctlyFEBS Letters, 1998
- Antibody scFv fragments without disulfide bonds, made by molecular evolutionJournal of Molecular Biology, 1998
- Intracellular Immunization with Cytosolic Recombinant AntibodiesBio/Technology, 1994
- Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.Proceedings of the National Academy of Sciences, 1993
- Single-Chain Antigen-Binding ProteinsScience, 1988
- Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.Proceedings of the National Academy of Sciences, 1988